multipl path creat valu
new dupont face strateg fork road posit
organ re-rat time true multi-industri
compani ii seek inorgan maxim valu
four distinct oper segment creat valu
think investor prefer latter
initi coverag dupont overweight rate price target
base sotp valu friday close long indic view
dupont valuat peer set includ multi-industri compani
cover joshua pokrzywinski whose estim compani use
throughout believ equiti market yet convinc
recogn like take time also long
indic view dupont could separ current
conglomer structur one way anoth four individu compani
believ stock current trade ebitda versu
sotp equiti market see risk ebitda forecast
perhap base still challeng macro condit lack trade
resolut us china lack recoveri auto and/or
electron market manag indic pull cost lever get
guidanc need sway investor sentiment ii
noth structur strateg like announc septemb
two-year anniversari dowdupont merger capit gain tax
reason creat less incent stock report iii time
valu money risk associ potenti break-up long
take realiz valuat uplift worth wait iv pfa
liabil overhang may exist could continu time
expect comparison dupont signific part
invest debat dupont line well underli busi
mix revenu cagr ebit margin capit intens metric
analysi show core drive multi-industri multipl dupont
meaning overlap across dupont segment well similar geograph
end market mix forecast revenu growth profil compani
estim dupont ex-dowdupont merger
relat amort goodwil low end key multi peer
honeywel illinoi tool work high-teen rang
appreci support
institut investor all-america
research survey request ballot
chemic unit state america
unless otherwis note metric base modelwar
consensu data provid thomson reuter estim
author materi act
capac attorney hold
materi intend either
legal opinion legal advic inform
provid herein provid possibl
outcom probabl outcom
result legal disput controversi
depend varieti factor includ
limit parti histor relationship law
pertain case rel litig talent trial
locat juri composit judg composit
investor contact legal advisor
issu law relat subject matter
materi
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
unadjust basi cover joshua pokrzywinski expect
dupont metric improv organ exist cost synergi
program inorgan compani shift presum
compani averag ebit margin sale non-core segment seek
buyer asset note face prefer dupont versu
detail
also remain view dupont continu maintain materi
discount versu probabl separ
compani four segment increas believ dupont could easili
becom four separ compani would surpris see
meaning sharehold pressur dupont either garner
higher multipl and/or begin exhibit share price out-performance next
twelv month dupont garner desir multipl view
obviou thing would isol valu nutrit
bioscienc segment initi pursuit strateg altern includ
potenti spin-off sale divis whole part
ostens alreadi done given manag consist
everyth tabl -type commentari fulsom step
direct would like caus equiti market effici valu
asset within overal dowdupont construct leav asid nutrit
bioscienc realli fit mold multi-industri industri compani
pure-play peer trade multipl gener excess multi-industri
compani christian hansen ebitda novozym
time givuadan cover alexandra thrum et
al base consensu estim given goodwil associ
danisco acquisit nutrit leav dupont weigh
total compani one key metric identifi drive
end also note substanti activ take place peer
electron compani strateg announc peer particular
note recent activ electron versum merg
merck came top offer versum came bit
surpris us view electron first area dupont
would need make strateg decis want
particip electron industri consolid also point
recent announc competitor dupont
transport advanc polym longtim ceo shift
non-execut chairman role like ed breen dupont time
announc consid transform opportun
busi may well offer opportun time dupont
also discuss separ asset final dupont shift sale
non-cor segment lead eventu monet
asset also meaning improv underli perform
return characterist core segment improv
valuat organ inorgan better sales/ebitda growth
margin
note share price declin april reflect new spin dwdp thomson reuter histor share price data
part peer compani ev/ebitda multipl rang
part ebitda
part ebitda
higher ebitda higher multipl strateg action end market
improv better expect follow trade resolut variou tax
effici valu creat strateg action chosen allow multipl expans
similar took place old dupont announc spin intent
part ebitda
part ebitda
dupont meet ebitda guidanc part fundament part
pull cost lever macro condit ultim stabil gener
move sideway compani pursu dual-track strategi tri improv
multipl organ inorgan
part ebitda
part ebitda
weak macro multipl contract synergi disappoint litig risk
synergi product initi off-set weak macro
lack trade resolut global econom deterior peer trade multipl
contract eat benefit strateg action real perceiv
share trade conglomer discount pfa liabil concern build
expect share outperform
manag pursu dual track strategi
posit organ re-rat
time true multi-industri compani
ii seek inorgan maxim
valu four distinct oper segment
long indic view
dupont valuat peer set includ
multi-industri compani
cover joshua pokrzywinski
believ equiti market yet
convinc recogn
like take time
also long indic view
dupont could separ current
conglomer structur one way anoth
four individu compani
automobil smart phone product
risk achiev price
oper manag abil
optim structur strateg
pfa liabil wors expect
becom overhang stock
get go
overview transact creat dupont de nemour dd decemb
chemic co du announc intent
consumm merger equal intent first combin respect
busi across three key vertic agricultur materi specialti
spin one stand-alon entiti would stronger
smaller busi within two larger conglomer legaci dupont
longer expect regulatori process compani close merger
septemb thu creat dowdupont dwdp year half later
dowdupont final complet process spin split newli
creat busi specif back april dowdupont spun materi
busi creat compani inc subsequ june ag
busi offici spun effect creat ag pure play compani
well specialti compani remainco dwdp immedi
chang name dupont de nemour inc began trade ticker dd
rest report focu dupont specialti co busi
exhibit timelin evolut merger/spin transact chemic dupont
initi coverag dupont overweight rate price target base
sotp valu friday close long indic view dupont
valuat peer set includ multi-industri compani cover
joshua pokrzywinski whose estim compani use throughout
believ equiti market yet convinc recogn
like take time also long indic view dupont could
separ current conglomer structur one way anoth four
individu compani believ stock current trade ebitda
versu sotp equiti market see risk ebitda
forecast perhap base still challeng macro condit lack trade
resolut china lack recoveri auto and/or electron market
manag indic pull cost lever get guidanc need
sway investor sentiment ii noth structur strateg
like announc septemb two-year anniversari
dowdupont merger capit gain tax reason creat less incent
stock report iii time valu money risk associ potenti
break-up long take realiz valuat uplift worth
wait iv pfa liabil overhang may exist could continu
time
exhibit bull bear base case number methodolog
part ev/ebitda
part ev/ebitda
part ev/ebitda
trade remain unsettl result end-market
weak auto electron
guidanc lower
strateg option price given
dd partli close gap multi-industri peer
multipl organ inorgan action
trade disput settl macro improv
cost lever
trade resolut lead sharper custom
restock expect
ebitda growth better expect
auto eletron end market pick
dd close valuat gap multi-industri peer
partli strateg option
exhibit dupont multipl discount high-qual ee/mi peer
expect comparison dupont signific part
invest debat dupont line well underli busi mix revenu
cagr ebit margin capit intens metric analysi show core
drive multi-industri multipl dupont meaning overlap across
dupont segment well similar geograph end market mix forecast
revenu growth profil compani global plu rate
dupont ebitda margin today trail estim dupont
ex-dowdupont merger relat amort goodwil low end
key multi peer honeywel illinoi tool work high-teen
rang unadjust basi expect dupont metric improv
organ exist cost synergi program inorgan
compani shift presum compani averag ebit margin sale
non-core segment seek buyer asset note face prefer
dupont versu detail
dupont line well underli busi mix revenu cagr ebit
margin capit intens metric analysi show core drive
multi-industri multipl dupont meaning overlap across dupont
segment well similar geograph end market mix forecast revenu
growth profil compani global plu rate dupont
ebitda margin today trail estim dupont
ex-dowdupont merger relat amort goodwil low end
key multi peer honeywel illinoi tool work high-teen low-
rang unadjust basi expect dupont metric improv
organ exist cost synergi program inorgan
compani shift presum compani averag ebit margin sale
non-cor segment seek buyer asset
exhibit dupont vs organ growth actual full-year guidanc
exhibit dupont specialti co product
probiotics/cultur food protect
photovolta adv materi
compet specialti co food
beverag industri peer higher
multipl
automot bond polym
build wrap window film
dupont transcend chemic gic valuat perspect
chemic sector like due commod orient upstream natur
trade multipl turn discount higher qualiti ee/mi despit gener
similar macro driver growth characterist theori put dupont
disadvantag despit multi-industri like busi model howev base
multipl product clearli possibl
achiev ebitda multipl well excess sector median howev three
compani fairli concentr distinct busi model wherea dupont
strike us multi-industri compani given four independ
diversifi oper segment say chemic gic
contain compani could consid multi-industri well howev
believ divid line whether compani upstream commod asset
drive downstream specialti busi margin case dupont
much case mani chemic compani
learn valuat transform sinc
sherwin ebitda multipl increas last three year rang
signific premium coat peer rang
somewhat in-lin consum hardlin retail stock
low respect sherwin comp
retail rather manufactur paint happen overnight clearli
equiti market look sherwin perform key metric
determin busi warrant higher multipl note sherwin
still chemic gic rare discuss valuat investor
chemic consum hardlines/retail
also remain view dupont continu maintain materi
discount versu probabl separ compani
four segment increas believ dupont could easili becom four
separ compani would surpris see meaning sharehold
pressur dupont either garner higher multipl and/or begin
exhibit share price out-performance next twelv month dupont
garner desir multipl view obviou thing would
isol valu nutrit bioscienc segment initi pursuit
strateg altern includ potenti spin-off sale divis whole
part ostens alreadi done given manag consist
everyth tabl -type commentari fulsom step direct
would like caus equiti market effici valu asset within
overal dowdupont construct leav asid nutrit bioscienc realli
fit mold multi-industri industri compani pure-play peer trade
multipl gener excess multi-industri compani christian hansen
ebitda novozym givuadan
cover alexandra thrum et al base consensu estim given
goodwil associ danisco acquisit nutrit leav
dupont weigh total compani one key metric
identifi drive multi-industri ebitda multipl
end also note substanti activ take place peer electron
compani strateg announc peer particular note
recent activ electron versum merg merck came
top offer versum came bit surpris us
view electron first area dupont would need make strateg
decis want particip electron industri consolid
also point recent announc competitor
dupont transport advanc polym longtim ceo shift
non-execut chairman role like ed breen dupont time
announc consid transform opportun
busi may well offer opportun time dupont also discuss
separ asset final dupont shift sale non-cor segment
lead eventu monet asset also meaning
improv underli perform return characterist core segment
improv valuat organ inorgan better
sales/ebitda growth margin
base case sotp analysi result price target dupont
given dupont four distinct busines believ sum part valuat
approach appropri analysi use peer compani ev/ebitda multipl
rang result overal ev/ebitda dupont
electron imag segment use versum materi vsm
microelectron peer group
nutrit bioscienc segment use dsm dsm intern flavor fragranc
novozym nzymb givaudan givn peer group
transport advanc polym segment use illinoi tool work lanxess
lx ce peer group appli
premium adjust specialti natur dupont ap segment
peer multipl may weigh exposur commod busi
acetyl acet tow net valu ap multipl back
engin materi busi final safeti construct
segment use basic energi servic
ba wacker chemi wch peer group
sotp impli ev/ebitda multipl long indic view
dupont valuat peer set includ multi-industri compani
cover joshua pokrzywinski whose estim compani use throughout
believ equiti market yet convinc recogn
like take time also long indic view dupont
could separ current conglomer structur one way anoth
four individu compani believ stock current trade
ebitda versu sotp equiti market see risk
ebitda forecast perhap base still challeng macro condit lack
trade resolut china lack recoveri auto and/or electron market
manag indic pull cost lever get guidanc need
sway investor sentiment ii noth structur strateg
like announc septemb two-year anniversari
dowdupont merger capit gain tax reason creat less incent
stock report iii time valu money risk associ potenti
break-up long take realiz valuat uplift worth
wait iv pfa liabil overhang may exist could continu
time
ev/ebitda multipl comp
million except per share data
af equiti method invest
see number reason like new dupont strateg option clear
intent know-how base execut chairman ed breen prior experi tyco
growth potenti due improv effici increas focus
revenu growth though somewhat macro depend seen
year greater intern focu key financi metric oper leverag
view new dupont special situat co given mr breen histori pursu
strateg altern tyco marc doyl previous dwdp specialti
product divis compani ceo ed breen name execut
chairman role indic full time job mr breen consist indic
everyth tabl strateg option perspect one need
look willing merg enter signific tax free asset
swap see could mean go forward expect portfolio option
big driver stand-alon multipl near term investor laser-focus
anniversari dowdupont merger septemb ir
perspect compani would free pursu tax-fre strateg
option saw fit
recent comment made dupont execut regard strateg option
ed breen earn call consid full rang
strateg option busi non-cor segment best interest
sharehold key stakehold mind
ed breen investor day focu
bigger thing capit get alloc compani drive
strateg decis marc board want take
compani back question got earlier portfolio stay way
want anyth type thing think big lever
jeanmari desmond cfo investor day ed marc
outlin robust strategi focus divest product
line longer best owner make acquisit fit within
core compet deliv solid return
marc doyl investor confer importantli
interest pursu sharehold valu portfolio evolv time
strateg question investor hold togeth
valu creat opportun piec pursu
whatev think creat sharehold valu road
marc doyl investor confer sort question
longer term four specialti product segment hold togeth
point noth say continu
pursu best strategi sharehold long run open
pursu differ option road
issu trade dupont trade ev/ebitda mulitpl greater
turn ev/ebitda discount multi-industri peer despit dupont line well
underli busi mix revenu cagr ebit margin capit intens
metric analysi show core drive multi-industri multipl dupont
meaning overlap across dupont segment well similar geograph
end market mix forecast revenu growth profil compani global
estim dupont ex-dowdupont merger relat amort
goodwil low end key multi peer honeywel
work high teen low twenti rang unadjust basi expect
dupont metric improv organ exist cost synergi
program inorgan compani shift presum compani
averag ebit margin sale non-core segment seek buyer
asset detail pleas see face prefer dupont versu
exhibit dupont dd current trade ev/ebitda multipl
improv growth potenti due improv effici increas focus
target growth though somewhat macro depend
seen year novemb analyst day compani outlin
segment abl grow least multipl driven number
secular growth trend well on-going investments/improv target
dissimilar recent organ growth deliv busi shown exhibit
importantli compani expect deliv higher end rang
normal econom environ today innov big part
growth compani target increas new product percentag sale
last five year current level separ also expect
use bolt lever acceler supplement organ growth
roughli dividend expect year compani plenti
annual fire power make number tuck-in acquisit bolster growth
capabl view top-line growth target posit encourag
comment manag around disciplin capit alloc effici
marc doyl investor day say point
key criteria go use judg opportun
product differenti financi perform industri competit
posit cours high return invest potenti opportun
scrutin lens must deliv meaning valu
portfolio possibl current set busi
jeanmari desmond investor day current new product compris
sale focus bring top-quartil level
expect growth new product sale drive top line also
deliv margin expans increas oper leverag
exhibit dupont vs organ growth actual full year guidanc
greater intern focu key financi metric drive greater work capit
capit alloc effici believ partli underli sell-off
dowdupont share earn investor sentiment dupont
segment may chang significantli compani cultur
manag strategi natur go element show
new dupont given run day-to-day basi old dupont execut
nonetheless encourag number crucial chang made improv
account track oper effici compani
 first obviou one compani disclosur
incorpor determin execut compens
current dupont sit back merger relat
goodwil intang compani guid medium-term
target greater annual improv
oper leverag dupont commit oper leverag medium-
term target driven on-going product gain complet
cost synergi program end compani expect realiz
save
corpor cost expect less sale spin run rate basi
 dupont commit free cash flow convers greater
exhibit new dupont execut compens yet announc expect
significantli improv account align sharehold metric
element compens
target median select peer group gener
industri market data applic
target align appropri revenu size
select peer group gener industri market
data applic
paid cash base
paid cash base
entir award cap target
ad
paid cash base
entir award cap target
risk invest thesi still challeng macro condit lack
trade resolut china need improv auto and/or
electron market order hit guidanc equiti market may still elect
ass conglomer discount time valu money risk associ
potenti break-up long take realiz valuat uplift
worth wait pfa liabil overhang may exist could continu
time
still challeng macro condit lack trade resolut us
china need improv auto and/or electron market order
hit guidanc came larg in-line compani lower
expect guidanc manag maintain full year guidanc indic
would show meaning sequenti improv year becam even
back half load natur concern investor given focu us
china trade resolut well improv smart phone auto product
dynam howev believ recent neg share price perform suggest
risk larg price point would also note issu
exist almost chemic multi-industri compani
equiti market may still elect ass conglomer discount dupont
combin numer busi legaci legaci dupont
busi alloc four discret segment question remain
whether four segment realli belong togeth dupont multi-industri
compani hold compani investor percept latter conglomer
time valu money risk associ potenti break-up long
take realiz valuat uplift worth wait one thing investor
learn past year transact spin-off et al
talk longer cost origin anticip number reason
anti-trust review carv financi et al saw dow/dupont sherwin-
williams/valspar bayer/monsanto linde/praxair present unit
technolog thu like investor enthusiasm compani
begin pursue/announc strateg option also possibl signific time
valu discount may requir equiti market mean time
pfa liabil concern tie legaci dupont asset juli legaci dupont
spun-off perform chemic busi histor
use perfluorooctano acid pfoa manufactur teflon cook ware
product although prior spin compani alreadi discontinu use
today dupont along spin-off name sever
environment person injuri case clear issu on-going
disclos year howev confluenc follow recent event
creat concern invest commun size eventu liabil
pay comment promin investor liabil
billion billion ii disclosur legal entiti
hous pfa liabil transfer dupont spin
iii confidenti file lawsuit dupont given
complex associ estim potenti remedi need larg
dispar investor claim billion billion compani recent
accrual estim sub intellectu ground estim
instead simpli assum midpoint two extrem
billion current understand unabl pay liabil
full bankruptci protect would pay balanc sheet liabil
million follow increment dupont next million
two compani would split remaind corteva/dupont
pfoa pfoa man-mad surfact use variou chemic process
industri applic carpet upholsteri apparel floor wax textil
sealant cookwar legaci dupont use pfoa product teflon product
howev discontinu use polymer process aid prior spin
favor newli introduc genx product
dupont specialti co remain busi dowdupont complet spin-
ag co june shown exhibit remain entiti
amalgam dupont busi well acquir health
nutrit busi busi gener sale roughli
ebitda pre-corpor cost upon complet origin merger
busi reorgan four discret divis close align
term product end-market electron imag transport
advanc polym ap safeti construct nutrit bioscienc
 furthermor begin first stand-alone compani quarterli
report dupont disclos fifth segment call non-cor hous roughli
sale ebitda includ hemlock equiti incom
non-cor segment shown number busi dupont
determin lower margin growth profil compar rest
portfolio strateg believ better owner divestitur
asset timelin specifi would complet dupont target divest
exhibit portfolio transit dupont/dow merger dupont remainco
automot system adhes fuid platorm
process solut
pharma food solut
exhibit benchmark dupont versu subset multi-industri peer sever key metric
base show compani financi profil well align group
electron imag gener sale ebitda
segment lead supplier differenti materi system consum
electron photovolta display advanc print semiconductor result
high qualiti perform lower cost ownership custom consum
electron market growth driven smart phone busi portfolio
materi semiconductor fabric packag well circuit applic
pv market segment offer metal past backsheet materi
optim effici lifetim solar cell solar modul packag
graphic provid flexograph print system pigment ink use digit
print applic diversifi product slate reach market industri
commun consum data process auto military/aerospac
dupont note grow either fast display technolog
styren block copolym color dye us canada account roughli
segment sale competitor includ versum
microelectron
transport advanc polym gener sale ebitda
lubric part optim perform reduc system cost enhanc
sustain product segment serv custom transport
electron healthcar industri consum end-market raw materi includ
purifi terephthal acid silicon competitor includ em
growth driver overal growth dupont estim medium
term broadli driven macro factor global automot sale given larg
exposur transport longer term compani see signific growth
opportun driven innov abil particip mega trend
electricif vehicl estim revenu per vehicl would closer
greater increas versu intern combust engin
vehicl shown morgan stanley auto team forecast vs batteri
electr vehicl sale bev longer term signific exposur type trend could
drive signific growth long term
safeti construct gener sale ebitda
segment deliv product end market industri construct consum
transport medic devic water purif separ highli regard
brand like corian kevlar tyvek filmtec manufactur high strength thermal-
resist select barrier solid surfac revers osmosi element insul
materi use everyth personnel protect militari
emerg respons waterproof roof packag materi major raw
monoxid chlorin high-dens polyethylen competitor honeywel
industri
nutrit bioscienc gener sale ebitda
segment made two sub-busi nutrit industri
bioscienc nutrit provid rang sustain bio-bas
ingredi deliv innov solut specialti food ingredi food
nutrit health safeti product solut includ cultur probiot emulsifi
textur natur sweeten soy-bas food ingredi segment serv end
market within food industri dairi bakeri meat beverag raw
materi cellulos gelatin glycerol guar organ oil competitor
novozym chr hansen lonza croda
industri bioscienc ib leader develop manufactur portfolio
bio-bas product segment enzym add valu function process
product across market anim nutrit deterg food manufactur
ethanol product industri applic product line result cost
process advantag improv perform sustain environment outcom
addit clean technolog deliv process design engin solut
help organ becom safer effici reduc emiss raw materi
input includ terephthal acid process grain glycol
exhibit bridg specialti product dupont stand-alone ebitda
million unless otherwis state
million unless otherwis state
restructur charg
equiti earn nonconsolid affili
interest expens amort debt discount
incom incom tax
provis incom tax
net incom loss attribut non-controlling interest
prefer stock dividend
net incom loss avail dupont common stockhold
million unless otherwis state
cash equival
account note receiv
defer charg asset
current matur lt debt
accru current liabil
pension postretir benefit
total non-current liabiliit
accumul comprehens loss
total liabil equiti
million unless otherwis state
amort intang merger relat step
earn nonconsolid affili less excess dividend receiv
net gain sale asset busi invest
net gain step acquisit nonconsolid affili
restructur asset relat charg net
asset liabil net
oper
invest ga field develop
construct asset pend sale/leaseback
proce sale/leaseback asset
purchas previous leas asset
payment escrow account
distribut escrow account
proce sale properti busi net cash divest
acquisit properti busi net cash acquir
acquir merger transact
acquir step acquisit nonconsolid affili
invest loan nonconsolid affili
distribut loan repay nonconsolid affili
proce sale ownership interest nonconsolid affili
purchas invest
proce sale matur invest
use invest
borrow repay note payabl
proce issuanc long-term debt
payment long-term debt
purchas treasuri stock
proce issuanc compani stock
proce sale common stock
employe tax paid share-bas payment arrang
distribut non-controlling interest
purchas non-controlling interest
issuanc redempt prefer stock
borrow repay short-term borrow capit leas oblig
financ activ
effect exchang rate chang cash
restrict cash cash reclassifi held sale includ current asset
net chang
begin period
end period
valuat methodolog risk price target
price base base ntm ep assum flat
growth weaker auto/electron model organ growth
rebound core increment margin
time frame multipl assum premium broader ee/mi industri
risk achiev price
major busi lever gener industri short cycl
broader industri slowdown could disproportion impact
abil hit lt target
